Ganglionic Local Opioid Analgesia at the Ganglion Cervicale Superius
NCT05257655
Atypical Facial Pain, Cranial Nerve Diseases
Klagenfurt, Austria
View Trial DetailsNCT Number: NCT05101577
This study aims to find recurrence rate of the trigeminal neuralgia after patients undergo stereotactic rhizotomy by radiofrequency ablation at 80 degrees Celsius for 90 seconds under fluoroscopic guidance, a protocol that was modified from the originally described parameters for rhizotomy by John Tew, Chad J. Morgan and Andresw Grande et al. The presumption being that the higher temperature of the probe tip would lead to a more long-lasting lesion and lesser recurrence, but at the cost of more frequent sensory and motor deficits.
Looking for future studies?
Notify Me27 year–91 year
All sexes
Observational
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Recurrent paroxysms of unilateral facial pain in the distribution(s) of one or more divisions of the trigeminal nerve, with no radiation beyond, and fulfilling criteria B and C
A. Pain has all of the following characteristics:
Exclusion criteria
Time frame: Recurrence within 12 months of the intervention
Recurrence of pain in the same distribution of the trigeminal nerve branch or branches for which the stereotactic rhizotomy was originally performed
Time frame: 5 years
locally deviced protocol for stereotactic rhizotomy of the involved trigeminal gangion dictates the use of higher temperature of 80 degree Celsius for 90 seconds, which translates into better pain relief and longer pain free intervals at the cost of higher percentage of sensory and motor deficits
Shifa Clinical Research Center
Other
Recurrence Rate of Trigeminal Neuralgia in Patients Treated With Percutaneous Stereotactic Continuous Radiofrequency Rhizotomy at 80 Degrees Celsius for 90 Seconds- a Single Center Study.
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05257655
Atypical Facial Pain, Cranial Nerve Diseases
Klagenfurt, Austria
View Trial DetailsNCT06472323
Cranial Nerve Diseases, Facial Nerve Diseases
Beijing, Beijing Municipality, China
View Trial DetailsNCT06620172
Agnosia, Cranial Nerve Diseases
Zagazig, Sharqia Province, Egypt
View Trial DetailsNCT01134575
Acute Lymphoblastic Leukemia, Burkitt Lymphoma
Houston, Texas, United States
View Trial Details